Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical strategy of diagnosing and following patients with nonalcoholic fatty liver disease based on invasive and noninvasive methods.

Journal of gastroenterology - 1 Feb 2018

Yoneda Masato, Imajo Kento, Takahashi Hirokazu, Ogawa Yuji, Eguchi Yuichiro, Sumida Yoshio, Yoneda Masashi, Kawanaka Miwa, Saito Satoru, Tokushige Katsutoshi, Nakajima Atsushi

Abstract excerpt

Nonalcoholic fatty liver disease (NAFLD) is an important cause of chronic liver injury in many countries. The incidence of NAFLD is rising rapidly in both adults and children, because of the currently ongoing epidemics of obesity and type 2 diabetes. Notably, histological liver fibrosis is recognized as the main predictive factor for the overall long-term outcome of NAFLD, including cardiovascular disease and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Biopsy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Elasticity Imaging Techniques

Share to Genetic Predisposition to Disease

Share to Magnetic Resonance Imaging

Share to Non-alcoholic Fatty Liver Disease

Share to Severity of Illness Index

Source

Open in PubMed Open full text

Identifiers

PMID: 29177681
DOI: 10.1007/s00535-017-1414-2
PMCID: PMC5846871

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical strategy of diagnosing and following patients with nonalcoholic fatty liver disease based on invasive and noninvasive methods.PMID 29177681Read ↗

Liver Fibrosis Conventional and Molecular Imaging Diagnosis UpdateSemantic proximity Read ↗

Non-alcoholic fatty liver disease: what the clinician needs to know.Semantic proximity Read ↗

Nonalcoholic Fatty Liver Disease 2020: The State of the Disease.Semantic proximity Read ↗

Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.Semantic proximity Read ↗

FIB-4 First in Diagnostic Algorithm of MAFLD at the Era of “Global Metabodemic “Semantic proximity Read ↗

Nonalcoholic fatty liver disease in children: recent practice guidelines, where do they take us?Semantic proximity Read ↗

Recent advances in understanding and managing non-alcoholic fatty liver diseaseSemantic proximity Read ↗

Nonalcoholic fatty liver disease test: an external validation cohort.Semantic proximity Read ↗

Steatosis Non-Invasive Tests Accurately Predict Metabolic Dysfunction-Associated Steatotic Liver Disease, While Fibrosis Non-Invasive Tests Fall Short: Validation in U.S. Adult PopulationSemantic proximity Read ↗

Non-alcoholic Fatty Liver Disease (NAFLD) Management in the CommunitySemantic proximity Read ↗

Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future.Semantic proximity Read ↗

Natural History of NAFLDSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.